South Dakota Court Revives Cymbalta Suicide Case

A federal appeals court has reversed a lower court’s summary judgment in favor of Eli Lilly,   allowing the parents of a South Dakota teenager who committed suicide while taking the antidepressant Cymbalta to sue the drug’s makers for failure to warn and deceit. The prescribing doctor did not know that there was an FDA “black box” warning on the drug, informing about the increased risk of suicidality in children and teens. The Cymbalta samples given to the doctor had been removed from their packaging and contained no warning information.

Article →